Dror Bashan
President and CEO, Director at Protalix BioTherapeutics, Inc. (PLX)
Dror Bashan has filed 9 insider reports with the SEC since February 2022, as president and CEO and director at Protalix BioTherapeutics, Inc. (PLX). In the last 12 months Dror Bashan bought $101K of stock on the open market. The latest filing, on September 4, 2026, reports grant or award at Protalix BioTherapeutics, Inc. (PLX).
- Filings
- 9
- Companies
- 1
- Bought on market
- $294K
- Sold on market
- None
Companies where Dror Bashan is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| PLX Protalix BioTherapeutics, Inc. | President and CEO, Director | 188,516 | $294K | $1.56 | $2.54+63% | Sep 4, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Sep 3, 2026PLXSEC Form 4 filed by PRESIDENT AND CEO Bashan DrorForm 4Grant or award
- Dec 19, 2025+$101KPLXPRESIDENT AND CEO Bashan Dror bought $101,360 worth of shares (56,000 units at $1.81), increasing direct ownership by 42% to 188,516 unitsForm 4/AOpen-market purchase
- Sep 3, 2025PLXPRESIDENT AND CEO Bashan Dror was granted 195,000 sharesForm 4Grant or award
- Apr 1, 2024PLXBashan Dror was granted 263,960 sharesForm 4Grant or award
- Oct 19, 2023+$90.5KPLXBashan Dror bought $90,484 worth of shares (64,516 units at $1.40), increasing direct ownership by 95% to 132,516 unitsForm 4/AOpen-market purchase
- Aug 15, 2023PLXSEC Form 4: Bashan Dror was granted 800,000 sharesForm 4Grant or award
- Sep 7, 2022PLXSEC Form 4 filed by Bashan DrorForm 4Grant or award
- Apr 11, 2022+$102KPLXSEC Form 4: Bashan Dror bought $102,000 worth of shares (68,000 units at $1.50)Form 4Open-market purchase
- Feb 25, 2022PLXSEC Form 4: Bashan Dror was granted 637,531 sharesForm 4Grant or award
Compare Dror Bashan with
- Dror Bashan vs Aharon Schwartz1 shared
- Dror Bashan vs Christian Elze1 shared
- Dror Bashan vs Yaron Naos1 shared
- Dror Bashan vs Zvi Shmuel Ben1 shared
- Dror Bashan vs Pol F Boudes1 shared
- Dror Bashan vs Gwen A Melincoff1 shared
Other insiders at the same companies
- Aharon SchwartzPLX
- Christian ElzePLX
- Zvi Shmuel BenPLX
- Yaron NaosPLX
- Amos Bar-ShalevPLX
- Gwen A MelincoffPLX
- Pol F BoudesPLX
- Eliot ForsterPLX
- Gilad MamlokPLX
Questions about Dror Bashan
- What is Dror Bashan's role at Protalix BioTherapeutics, Inc.?
- Dror Bashan reports to the SEC as president and CEO and director at Protalix BioTherapeutics, Inc. (PLX), according to the latest filing on September 4, 2026.
- How many shares does Dror Bashan own?
- After the latest filing that states it, Dror Bashan directly owned 188,516 shares of Protalix BioTherapeutics, Inc. (PLX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Dror Bashan bought or sold stock recently?
- The most recent open-market purchase was on December 19, 2025: bought 56,000 shares of Protalix BioTherapeutics, Inc. (PLX) for $101K at an average of $1.81.
- How do I get alerts when Dror Bashan files?
- Follow Dror Bashan on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Dror Bashan filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Dror Bashan (SEC CIK 0001781450). Totals count each trade once, skipping amendments whose original is on file, from Feb 28, 2022 on. View on SEC EDGAR